PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies-Reference-Cited by-同舟云学术

PD-L1 Glycosylation and Its Impact on Binding to Clinical Antibodies

Published:2020-10-19 Issue:1 Volume:20 Page:485-497
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Benicky Julius¹²,Sanda Miloslav¹²^ORCID,Brnakova Kennedy Zuzana¹²,Grant Oliver C.³,Woods Robert J.³^ORCID,Zwart Alan¹,Goldman Radoslav¹⁴²^ORCID

Affiliation:

1. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C. 20057, United States

2. Clinical and Translational Glycoscience Research Center, Georgetown University, Washington, D.C. 20057, United States

3. Department of Biochemistry and Molecular Biology, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States

4. Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, D.C. 20057, United States

Funder

National Cancer Institute

NIH Office of the Director

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.0c00521

Reference43 articles.

1. The blockade of immune checkpoints in cancer immunotherapy

2. B7 family checkpoint regulators in immune regulation and disease

3. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections

4. Emerging Co-signaling Networks in T Cell Immune Regulation

5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Effectiveness of PD-L1 Tumoral Expression in Oral Cavity Squamous Cell Carcinoma;Indian Journal of Surgical Oncology;2024-06-26

2. Experimentally Determined Diagnostic Ions for Identification of Peptide Glycotopes;Journal of Proteome Research;2024-06-18

3. PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET;Frontiers in Immunology;2024-06-10

4. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

5. Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways;Experimental Hematology & Oncology;2024-04-23